What You Missed at the 3rd ADC Linker & Conjugation Summit 2025
With all eyes on novel linker designs and new conjugation chemistry to move beyond the traditional, the 2025 ADC Linker & Conjugation Summit spotlighted innovations that can elevate ADC performance to a whole new level.
This was the only ADC meeting that offered a technical program purpose-built for specialists in chemistry, bioconjugation, and protein engineering, going far beyond surface-level overviews or what was already in the literature.
At this summit, you weren't lost in a crowd, you were surrounded by peers with the same job titles and technical focus. It was a highly curated environment where every conversation mattered, and every detail was relevant.
2025's Agenda Highlights:
Enhancing Conjugation Chemistry for Dual-Payload ADCs
Unlocking the synergistic potential of dual-payload ADCs by exploring branched linker designs and advancing innovative conjugation chemistry with Sutro Biopharma, Catena Biosciences, and Araris Bio.
Next-Generation Conjugation Strategies
Moving away from maleimide chemistry - exploring the potential of next-generation conjugation strategies and site-specific technologies with Skymab Therapeutics, AstraZeneca, and Pfizer.
Advancing Linker Design Strategies
Achieving optimal stability profiles by showcasing new linker structures and discussing how to balance stability with controlled cleavage with NextPoint Therapeutics, Oncusp Therapeutics, and Glykos.
Innovative Linker & Conjugation Strategies
Overcoming novel payload challenges by utilizing solubility enhancers and tailored linker designs with Tubulis and Heidelberg Pharma
Deep Dive Sessions on Conjugation Site & DAR Stability
Join focused sessions to identify the optimal conjugation site and optimize the DAR/stability balance with Exelixis, ADC Therapeutics, and Glykos.
Explore the Full 2025 Event Guide
- 18+ World Class Speakers
- 3 Days of Dedicated Linker & Conjugation Content
- Exclusive Networking & Partnering Opportunities
Speaking Companies for 2025:
Explore the 2025 Agenda
Hear the latest industry-led breakthroughs and gain exclusive insights on linker and conjugation strategies during our packed agenda, discussion sessions and structured networking.
Partner With Us
Join leading ADC developers exploring ways to improve the therapeutic window through optimized linker and conjugation chemistry. Connect with top platform providers, CDMOs, and CROs to position your brand at the forefront of a competitive market.
Join Biopharma Experts
Be part of the hottest conversations with like-minded attendees spanning all stages of drug development and make critical connections during our dedicated networking sessions.